TGFB1 and Hepatic fibrosis: Our previous study demonstrated that octreotide, an analog of somatostatin, significantly inhibited CCl4-induced hepatic fibrosis and TGF-β1-induced activation of LX-2 cells through suppression of the Wnt/β-catenin signaling pathway (Zhang et al., 2018).